Table 2.
Variable | RDW | p-Value | Survival (d) | p-Value |
---|---|---|---|---|
Age (month) | 0.206 | 0.013 | −0.261 | 0.002 |
Weight (kg) | 0.091 | 0.275 | −0.092 | 0.268 |
Sex—Male | −0.047 | 0.575 | 0.039 | 0.638 |
Breed—Pure breed | 0.059 | 0.480 | −0.041 | 0.623 |
Cardiac treatment Vs. No Treatment | 0.159 | 0.113 | −0.359 | <0.001 |
Mixed treatment/disease Vs. No Treatment | 0.087 | 0.468 | −0.301 | 0.010 |
Other treatment/disease Vs. No treatment | 0.075 | 0.494 | −0.151 | 0.164 |
ACVIM stage C + D | −0.211 | 0.011 | −0.265 | 0.001 |
AF | 0.031 | 0.707 | −0.123 | 0.139 |
PH | 0.101 | 0.226 | −0.122 | 0.142 |
Urea (mg/dL) | 0.109 | 0.191 | −0.342 | < 0.001 |
Total protein (g/L) | 0.188 | 0.024 | 0.082 | 0.326 |
Albumin (g/L) | 0.007 | 0.936 | 0.142 | 0.087 |
Creatinine (mg/dL) | 0.031 | 0.712 | −0.135 | 0.105 |
WBC (103/μL) | −0.056 | 0.499 | −0.388 | <0.001 |
RBC (106/μL) | −0.193 | 0.020 | 0.054 | 0.516 |
Hemoglobin (g/dL) | −0.329 | < 0.001 | 0.051 | 0.540 |
Hematocrit (%) | −0.322 | < 0.001 | 0.061 | 0.462 |
RDW (%) | NA | NA | −0.171 | 0.040 |
MCV (fL) | −0.277 | 0.001 | 0.030 | 0.718 |
Platelet (103/μL) | 0.119 | 0.152 | −0.035 | 0.677 |
LA/Ao | −0.123 | 0.138 | −0.352 | < 0.001 |
LVDDn | −0.246 | 0.003 | −0.175 | 0.034 |
LVSDn | −0.163 | 0.050 | −0.144 | 0.082 |
FS (%) | −0.024 | 0.778 | −0.015 | 0.861 |
E-max (cm/s) | −0.087 | 0.300 | −0.282 | 0.001 |
TR Vmax (m/s) | 0.094 | 0.306 | −0.249 | 0.006 |
Survival (d) | −0.171 | 0.040 | NA | NA |
ACVIM: American College of Veterinary Internal Medicine; AF: atrial fibrillation; PH: pulmonary hypertension; WBC: white blood cell; RBC: red blood cell; RDW: red cell distribution width; MCV: mean corpuscular volume; LA/Ao: left atrial to aortic root diameter ratio; LVDDn: left ventricular diastolic diameter normalized for body weight; LVSDn: left ventricular systolic diameter normalized for body weight; FS: fractional shortening; E-max: trans-mitral peak E-wave velocity; TR Vmax: peak velocity of tricuspid regurgitation; NA: not applicable.